Replies to post #178024 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

ARRY an NWBO type company?

I admit I sold out of ARRY to early after being a log term long. My bad.

But here are some numbers for ARRY:

Cash+Securities: Over $400M

Revenue: Running around $40M/Q

Pipeline

[OK, the pipeline page clearly has some BS in it. Danoprevir shares shelf space with DCVax-prostate.]

They took the exact opposite approach of NWBO. They worked hard with BP to license their technology for "chump change" over the years so they did not have to dilute nearly as much.